Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
Journal of the Neurological Sciences
|
December 24, 2023
Hallmarks of spinal cord pathology in multiple sclerosis
Daniel Kreiter, Alida A Postma, Raymond Hupperts, et al.
Expert Review of Neurotherapeutics
|
June 1, 2021
Vitamin D supplementation in multiple sclerosis: an expert opinion based on the review of current evidence
Robin Boltjes, Stephanie Knippenberg, Oliver Gerlach, et al.
Multiple Sclerosis and Related Disorders
|
September 8, 2023
Effect of disease-modifying treatment on spinal cord lesion formation in multiple sclerosis: A retrospective observational study
Daniel Kreiter, Romy Spee, Audrey Merry, et al.
European Urology Focus
|
March 4, 2025
Sacral Neuromodulation in Multiple Sclerosis: The NEMISIS Study
Harry J Kendall, Armelle Knops, Oliver Gerlach, et al.
Plos One
|
December 5, 2025
Spinal cord lesions in relapsing-remitting multiple sclerosis: Prognostic value of intrathecal production of immunoglobulins
Daniel Kreiter, Niels Franken, Demmie Bouweriks, et al.
European Journal of Neurology
|
December 16, 2020
Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis
Max Mimpen, Anne-Hilde Muris, Linda Rolf, et al.
Journal of Neuroimmunology
|
February 2, 2021
NK/T cell ratios associate with interleukin-2 receptor alpha chain expression and shedding in multiple sclerosis
Max Mimpen, Linda Rolf, Anne-Hilde Muris, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
February 1, 2013
Objectifying specific and nonspecific effects of acupuncture: a double-blinded randomised trial in osteoarthritis of the knee
Max Karner, Frank Brazkiewicz, Andrew Remppis, et al.
Journal of Neuroimmunology
|
July 19, 2021
Proportions of circulating transitional B cells associate with MRI activity in interferon beta-treated multiple sclerosis patients
Max Mimpen, Jan Damoiseaux, William van Doorn, et al.
CNS Drugs
|
July 29, 2021
Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study
Giovanni Castelnovo, Oliver Gerlach, Mark S Freedman, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
Journal of the Neurological Sciences
|
December 24, 2023
Hallmarks of spinal cord pathology in multiple sclerosis
Daniel Kreiter, Alida A Postma, Raymond Hupperts, et al.
Expert Review of Neurotherapeutics
|
June 1, 2021
Vitamin D supplementation in multiple sclerosis: an expert opinion based on the review of current evidence
Robin Boltjes, Stephanie Knippenberg, Oliver Gerlach, et al.
Multiple Sclerosis and Related Disorders
|
September 8, 2023
Effect of disease-modifying treatment on spinal cord lesion formation in multiple sclerosis: A retrospective observational study
Daniel Kreiter, Romy Spee, Audrey Merry, et al.
European Urology Focus
|
March 4, 2025
Sacral Neuromodulation in Multiple Sclerosis: The NEMISIS Study
Harry J Kendall, Armelle Knops, Oliver Gerlach, et al.
Plos One
|
December 5, 2025
Spinal cord lesions in relapsing-remitting multiple sclerosis: Prognostic value of intrathecal production of immunoglobulins
Daniel Kreiter, Niels Franken, Demmie Bouweriks, et al.
European Journal of Neurology
|
December 16, 2020
Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis
Max Mimpen, Anne-Hilde Muris, Linda Rolf, et al.
Journal of Neuroimmunology
|
February 2, 2021
NK/T cell ratios associate with interleukin-2 receptor alpha chain expression and shedding in multiple sclerosis
Max Mimpen, Linda Rolf, Anne-Hilde Muris, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
February 1, 2013
Objectifying specific and nonspecific effects of acupuncture: a double-blinded randomised trial in osteoarthritis of the knee
Max Karner, Frank Brazkiewicz, Andrew Remppis, et al.
Journal of Neuroimmunology
|
July 19, 2021
Proportions of circulating transitional B cells associate with MRI activity in interferon beta-treated multiple sclerosis patients
Max Mimpen, Jan Damoiseaux, William van Doorn, et al.
CNS Drugs
|
July 29, 2021
Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study
Giovanni Castelnovo, Oliver Gerlach, Mark S Freedman, et al.
Page
of 6